CHINOOK TRANSPORTATION SERVICES

Chinook Transportation Services is a Transportation & Warehousing company.

#Website #More

CHINOOK TRANSPORTATION SERVICES

Industry:
Food Delivery Logistics Transportation

Address:
Yakima, Washington, United States

Country:
United States

Website Url:
http://www.chinookts.com

Status:
Active

Contact:
1-888-222-1019

Technology used in webpage:
SPF Microsoft Exchange Online Office 365 Mail GoDaddy DNS


Official Site Inspections

http://www.chinookts.com

  • Host name: ngcluster.msg.chrl.nc.charter.net
  • IP address: 47.43.22.53
  • Location: United States
  • Latitude: 37.751
  • Longitude: -97.822
  • Timezone: America/Chicago

Loading ...

More informations about "Chinook Transportation Services"

Novartis completes acquisition of Chinook Therapeutics

Acquisition of Chinook Therapeutics, a clinical-stage biopharmaceutical company, completed for USD 3.2bn upfront; Deal brings two phase 3 assets in development for IgAN; atrasentan, an โ€ฆSee details»

Chinook Therapeutics - LinkedIn

Chinook Therapeutics is now a Novartis Company! On August 11, 2023, Novartis completed its acquisition of Chinook. Follow Novartis to stay updated on atrasentan, zigakibart (BION-1301) โ€ฆSee details»

Novartis bolsters innovative medicines strategy and renal pipeline โ€ฆ

Jun 12, 2023 These documents (when available) may be obtained free of charge from the SECโ€™s website at www.sec.gov, Novartis website at https://www.novartis.com and Chinookโ€™s website โ€ฆSee details»

Novartis

Mar 28, 2025 Patient organization funding Payments to healthcare professionals Public policy A living wage A safe workplace Animal research Environmental, social and governance. Learn โ€ฆSee details»

Chinook Therapeutics - Crunchbase Company Profile & Funding

Www.chinooktx.com ; 16,106; Highlights. Acquisitions 1. obfuscated. Total Funding Amount . Unlock for free . Contacts 119. Employee Profiles 7. ... Furthermore, being part of a larger โ€ฆSee details»

Chinook Therapeutics Enters Into Agreement to be Acquired by โ€ฆ

Jun 12, 2023 The transaction is expected to be completed in the second half of 2023, subject to customary closing conditions.See details»

Chinook Therapeutics, Inc. - AnnualReports.com

Chinook Therapeutics, Inc. is a clinical-stage biopharmaceutical company developing precision medicines for kidney diseases. Chinookโ€™s product candidates are being investigated in rare, โ€ฆSee details»

Chinook Therapeutics, a Novartis Company Overview

Chinook Therapeutics is now a Novartis Company! On August 11, 2023, Novartis completed its acquisition of Chinook. Follow the Novartis channel or visit www.novartis.com to stay updated โ€ฆSee details»

Chinook Therapeutics

Feb 25, 2025 Chinook Therapeutics, Inc., a clinical-stage biotechnology company, focuses on the discovery, development, and commercialization of precision medicines for kidney diseases.See details»

Chinook Therapeutics Enters into Agreement to be Acquired

Jun 12, 2023 Novartis to acquire Chinook for $40 per share in cash, with potential to receive up to an additional $4 per share in cash through contingent value rights, for a total equity value of โ€ฆSee details»

Chinook Therapeutics - Craft

Chinook Therapeutics is a biotechnology company developing precision medicines for kidney diseases. It offers atrasentan, a potent and selective endothelin A (ETA) receptor antagonist; โ€ฆSee details»

Chinook Therapeutics, Inc. - Drug pipelines, Patents, Clinical trials ...

Ww.chinooktx.com. Public Company | Subsidiary Company | 2019 | Canada | 100-250 | NASDAQ: KDNY | ww.chinooktx.com. Last update 08 Mar 2025. Overview. Pipeline. Deal. Translational โ€ฆSee details»

Chinook Therapeutics - PitchBook

Chinook Therapeutics General Information Description. Chinook Therapeutics Inc is a clinical-stage biotechnology company. The products of the company are focused on rare, severe โ€ฆSee details»

CHINOOK THERAPEUTICS CLOSES MERGER WITH ADURO โ€ฆ

Combined CompanyWillHave Over $275 Million in Operating Capital andTrade on Nasdaq under the Ticker Symbol โ€œKDNYโ€ VANCOUVER, British Columbia and SEATTLE, Oct. 05, 2020 โ€ฆSee details»

Chinook Therapeutics Enters Into Agreement to be Acquired by โ€ฆ

Jun 12, 2023 Corporate Office. 623 Fifth Avenue 14th Floor New York, NY 10022. P: (212) 887-2100 E: [email protected]See details»

Chinook Therapeutics (KDNY) | Portfolio | Versant Ventures

Chinook is developing precision medicines for kidney diseases. The company is applying its proprietary discovery platform, which leverages single cell RNA sequencing, human-derived โ€ฆSee details»

Chinook Therapeutics Announces the Appointment of Robert W.

SEATTLE, April 13, 2023 (GLOBE NEWSWIRE) -- Chinook Therapeutics, Inc. (Nasdaq: KDNY), a biopharmaceutical company focused on the discovery, development and commercialization of โ€ฆSee details»

Chinook Therapeutics, A Novartis Company - Company Profile

Discover Chinook Therapeutics, A Novartis Company's contact details, including key employeesโ€™ emails and phone numbers. Explore company insights and data through Leadmap's company โ€ฆSee details»

Chinook Therapeutics Announces the Appointment of Robert W

SEATTLE, April 13, 2023 (GLOBE NEWSWIRE) -- Chinook Therapeutics, Inc., (Nasdaq: KDNY), a biopharmaceutical company focused on the discovery, development and commercialization โ€ฆSee details»

Chinook Therapeutics Inc: Locations - GlobalData

View Chinook Therapeutics Inc's company headquarters address along with its other key offices and locations.See details»